About
Cell Therapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyNJ, NY, PA
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
12
As Collaborator
2
Total Enrollment
1,106
By Phase
PHASE3: 5PHASE1/PHASE2: 4PHASE1: 1PHASE2: 2
By Status
COMPLETED: 6ACTIVE_NOT_RECRUITING: 4WITHDRAWN: 1ENROLLING_BY_INVITATION: 1TERMINATED: 1AVAILABLE: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT03997318Lead Sponsor
Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)
PHASE3Withdrawn
Started: Jun 30, 2025 · Completed: Jun 30, 2027
NCT06743620Lead Sponsor
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
N/AEnrolling by invitation
96 participants
Started: Apr 11, 2025 · Completed: Apr 30, 2032
NCT05776277Lead Sponsor
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury
PHASE3Active, not recruiting
200 participants
Started: Mar 21, 2024 · Completed: Sep 30, 2027
NCT05421689Collaborator
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
PHASE1/PHASE2Active, not recruiting
66 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
NCT03104517Lead Sponsor
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
PHASE3Active, not recruiting
96 participants
Started: Apr 23, 2019 · Completed: Sep 30, 2027
Locations (1)
Headquarters
Pittsburgh, PA, United States
Map
Loading map...